Despite its many advantages, Lung MAP faces several challenges:
Complexity: The master protocol approach is complex and requires meticulous coordination among various stakeholders. Patient Recruitment: Finding eligible patients who have undergone genomic profiling can be challenging. Regulatory Hurdles: Navigating the regulatory landscape to get multiple treatments approved within a single trial framework can be difficult.
